drugset / Trial / NCT00847834
Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
Parallel-groupOpen-labelTreatment
Summary
To analyse the control rate of irbesartan/hydrochlorothiazide(HCTZ) (COAPROVEL) in the treatment of patients with mild to moderate primary hypertension.
Timeline
- Start
- 2003-12
- Primary completion
- 2004-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Irbesartan | Small molecule | 150 mg | — |